chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around January 15, 2022 I felt like I was coming down with the flu. I got a cough and as the days went on it got deep and hurt so bad. I did not have a temperature. I lost my sense of taste. My tongue felt like burning your tongue with hot coffee. It still feels a little like that now. I still don't have my taste back the way it should be. I did not get a COVID test, but my wife tested positive for COVID a week or so after. I went to the doctor for a cough, and he prescribed prednisone. After I finished prednisone, the cough came back. He prescribed inhalers which are kind of controlling it.
14 hours post vaccine, mild muscle pain. 18 hours post vaccine began: lethargy, temp 99.5, joint pain, muscle aches.
Shortly after receiving the vaccine the patient called me over and stated she did not feel well.  I called 911.  Her body was itchy and she felt hot and sweaty.  Within the next few minutes she had a slight cough, itch in her throat, and redness/rash on her arms, legs, and chest.  She said she felt like someone was sitting on her chest.  1 dose of our store Epi Pen was administered and a few minutes later EMS arrived, evaluated the patient, and took her to the hospital.
Numbness and tingling to the right side of the face, the tongue also numb and tingling, right side of neck, the right should, right arm, and right hand to fingers. No facial drooping or difficulty speaking. Symptoms resolved in approximately 15 minutes. My husband was driving me to the hospital but did not seek medical care as symptoms resolved. We contacted our private physician in lieu of seeking medical attention.  No visit to doctor's office, consultation only as no permanent symptoms.  Physician has recommended not to receive second dose on November 1, 2021, as scheduled.
vaccine given at 1245 on 5/17. At 1300 complained of dizziness. 1325 noted rash around face, neck and upper back.
Information has been received from the physician concerning a 23 year old female who on 29-SEP-2010 was vaccinated IM with a first 0.5 ml dose of GARDASIL (lot # reported as 03372). Two hours following the administration of the first shot the patient began to feel nauseated, dizzy, and a sore throat, and had a temperature of 100 degrees. The patient had recovered at the same day as vaccination. She did not seek medical attention. The physician followed up with her after giving her the second 0.5 ml dose of GARDASIL (therapy route and lot # not provided) and no AE was reported. Follow-up information received from the physician indicated that the female patient with no pre-existing allergies and no illness at time of vaccination, was vaccinated IM on 29-SEP-2010 into left deltoid at 13:00 with a first 0.5 ml dose of GARDASIL. 2 hours after injection, at 15:00, patient felt sore throat, dizziness, sleepness and claimed she had temperature of 100 F. Patient noted this to the physician when she came for her second dose of GARDASIL injection on 30-NOV-2010. The patient did not seek medical attention. There was no diagnostic laboratory studies performed. Additional information is not expected.
Developed IBS and continue to have trouble. Went to primary care doctor and gastroentorolgist. They said wait and see if gets better.
1/17 had a rash at the site starting at 9 am . Now my whole body has a red raised rash . Face is the worst. Swollen and itches
Student vaccinator attempted vaccination on patient, needle did not penetrate skin on first attempt. Student then examined needle (patient states student touched needle; student states he did not touch needle) and student elected to reattempt IM injection. Vaccine successfully administered. Leadership informed of situation.
BLUISH, BLACKISH RIGHT THUMB; CHILLS; TIREDNESS; LETHARGY; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced lethargy. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced tiredness. On 02-APR-2021, the subject experienced bluish, blackish right thumb. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lethargy on 25-MAR-2021, and bluish, blackish right thumb on 05-APR-2021, and was recovering from chills, and tiredness. This report was non-serious.
Severe joint pain from pfizer bivalent 4th booster. Required steroid pack and then steroid injection along with flexibility. Lasting week and half so far. Also had reaction with 1st booster similar but not as bad.
tested positive for COVID after having the Pfizer COVID vaccine; tested positive for COVID after having the Pfizer COVID vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 5 (booster), single (Lot number: GH9693), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: EN9581), on 03Mar2021 as dose 2, single (Lot number: EN6203), on 11Oct2021 as dose 3 (booster), single (Lot number: 30135BA) and on 10Apr2022 as dose 4 (booster), single (Lot number: FK9894) for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (ongoing), notes: high blood pressure he is medicated for the high blood pressure; diagnosed 5 years ago; "prediabetic" (ongoing), notes: prediabetic diagnosed 5 years ago; "Fever" (unspecified if ongoing). Concomitant medication(s) included: INFLUENZA taken for immunisation; TYLENOL taken for pyrexia. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "tested positive for COVID after having the Pfizer COVID vaccine". The patient underwent the following laboratory tests and procedures: Blood test: (15Feb2023) normal, notes: everything for the tests was normal and he had no specific results to provide; Chest X-ray: (15Feb2023) normal, notes: everything for the tests was normal and he had no specific results to provide; Electrocardiogram: (15Feb2023) normal, notes: everything for the tests was normal and he had no specific results to provide; SARS-CoV-2 test: (15Feb2023) Positive, notes: He is still testing positive and went to the hospital on 15Feb2023; (26Feb2023) Positive, notes: Result: positive; Unit: Not Provided; (02Mar2023) Positive, notes: Result: positive; Unit: Not Provided. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course details: The patient was still testing positive and went to the hospital on 15Feb2023 and started Paxlovid that day and stopped it on the 19th or 20th of February. At the hospital they did blood tests, an EKG, and took a chest X-ray on 15Feb2023 and those were the only other tests that were done; everything for the tests was normal and he had no specific results to provide. The patient probably got a flu shot around the same time but he was not sure and he might have gotten it at the same time as the COVID vaccine but he does not remember and got the flu shot this year but was unsure if it was at same time as the COVID vaccine.
Pain at injection site after first dose; Redness at injection site after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site after first dose) and VACCINATION SITE ERYTHEMA (Redness at injection site after first dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site after first dose) and VACCINATION SITE ERYTHEMA (Redness at injection site after first dose). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 10-Mar-2021, VACCINATION SITE PAIN (Pain at injection site after first dose) and VACCINATION SITE ERYTHEMA (Redness at injection site after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-060007, US-MODERNATX, INC.-MOD-2021-060007 (E2B Linked Report). This case was linked to MOD-2021-063939 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060007: US-MODERNATX, INC.-MOD-2021-060007:
Immediately after the vaccine, I felt like I had a rock in my throat and started coughing. They gave me a Benadryl shot. It didn't make the symptoms go away, but it did stop them from getting worse. From 05/13/21 -05/16/21 I had blistering all over my gums and between my teeth and the inside of my cheeks. 5/17/2021 my sores did not hurt to touch I was able to brush my teeth. After about 6 days the blisters and sores were all gone.
Blood count -abnormal. Lymph nodes engorged, malar rash ,bruising on both arms, fever. No change in lupus antibodies.
Prickling needles feeling soles feet bilaterally and some in palms hands; pain in hip joints; moderate leg aches bilaterally; Sore arm at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 47-year-old female patient received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EJ1685), via an unspecified route of administration in the right arm, on 30Dec2020 at a single dose for COVID-19 immunization. The patient was 47 years old when she received the vaccine. Medical history included RSD (Reflex sympathetic dystrophy), had allergies to medications, food, or other product particularly NSAID and to contrast dye. The patient is not pregnant. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19 prior to vaccination. She had not been tested for Covid-19 since vaccination. The patient had sore arm at injection site for 36 hours after administration (02Jan2021) with outcome of recovered in Jan2021. In day #4 (03Jan2021), she had pain in hip joints and moderate leg aches bilaterally with outcome of unknown. In day #5 (04Jan2021), she had prickling needles feeling soles feet bilaterally and some in the palms of her hands with outcome of unknown. The events were reported as non-serious.   No follow-up attempts are possible. No further information is expected.
Lethargy, nausea, headache, malaise and other flu like symptoms (other), Feeling a little weak
At 1615 client informed EMT she "felt dizzy and her blood pressure was high". PHN arrived at 1618, client sitting upright in chair, alert and oriented x4. Per client has history of hypertension and pre-diabetes. Current medication Losartan and client stated she took medication this morning. Allergies to flu vaccine and cats. Vitals at 1818 by EMT: blood pressure 220/110, pulse 71, oxygen sat 99%. Client denies chest pain, shortness of breath, blurry vision, headache, or nausea. PHN retook blood pressure at 1824: 180/90. Per client feeling palpitations. Dizziness same, denies chest pain or shortness of breath. Vitals at 1826: blood pressure 180/90, pulse 71. Per client palpitations same. RN called 911 at 1830.  At 1833 client stated new onset of "feeling sleepy" and "eye heaviness". PHN continued to speak with client, client alert and oriented x4. PHN advised to follow up with provider. Fire Dept and Paramedics arrived at 1839 and assumed care. Client transported to Hospital at 1845.
No additional AE reported; An expired vaccine was administered to two patients; This spontaneous report was received from a physician, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 02-SEP-2021, the patient was vaccinated with an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 2 ml, orally, lot# 1691140, expiration date 10-JUL-2021, for prophylaxis (strength and frequency were not reported).  This is one of two reports received from the same source.; Sender's Comments:  US-009507513-2109USA001063:
This spontaneous report as received from a registered nurse refers to multiple unspecified patients who were administered vaccines which were stored improperly. This report refers to the patients who on unknown dates were vaccinated with PNEUMOVAX23 that were stored improperly. No adverse effects reported. Follow up information was from the same registered nurse who stated that patient identifiers and dates of administration were unavailable at this time; however, lot numbers and expiration dates were available: PNEUMOVAX23, lot # J009689, expiration date 29-JAN-2015. This is one of several reports received from the same reporter. Additional information has been requested.
Pressure Headache, tension headache, neck pain, tinnitus   Have had a pressure headache / tension headache / migraine type headache everyday since I received the 2nd shot. Started after the second shot and have had this in varying severity ranging from moderate to severe ever since. It is unrelenting and unresponsive to medication.
RASH AROUND MOUTH; This spontaneous report received from a patient concerned a 38 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 0180153 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for preventive (covid vaccine). No concomitant medications were reported. On 19-MAR-2021, the subject experienced rash around mouth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rash around mouth was not reported. This report was non-serious.
tachypnea and tickle in throat with first dose of Pfizer mRNA COVID-19 vaccine IM in right deltoid.  Taken to ED. Gave diphenhydramine 50 mg IV, famotidine 20 mg IV, and methylprednisolone 125 mg IV. Symptoms resolved and patient discharged in stable condition.
DIZZINESS, FEELING FAINT, HIGH BLOOD PRESSURE (175/104), TINGLING NUMBNESS AT INJECTION SITE, ALL WITHIN 15 MINUTES OF VACCINE
Injected high on the left arm into the shoulder joint.  Pain began immediately and arm was unusable for several days.  Range of movement has improved but there remains a dull chronic ache and the shoulder hurts to sleep on.  All other side effects from the covid vaccine itself resolved within 24 hours, but this has not gotten much better.
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. No information about medical history, concurrent conditions was reported for the patient. On 02-APR-2015 the patient was vaccinated inadvertently with oral, ROTATEQ (dose strength unspecified) which expired on 31-MAR-2015. No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. Additional information has been requested.
After the vaccine I developed a red ball on my arm and pain in my armpit, I am short of breath. After 2 days I feel like vomiting, I felt like I had a sudden cold, a lot of muscle pain, I was short of breath, panic attacks, chest pressure and tachycardia. And from then on I noticed the migraine starting in July/August each day stronger and now in Nov/Dec it has given me a very strong back pain and my oxygenation had dropped again. I went to the doctor and he told me to watch him because it was the migraine, I also felt a lot of itching and they gave me an injection for the migraine. The ball in my armpit was the size of a ping-pong ball
Hives as of the 17th of January 2022 lasted two days. Then as of today January 20th Thursday I have had chills headache cough fever of 100.4 nasal congestion runny nose tiredness fatigue
Chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced chills, headache, and fatigue. Event took place after use of product. The outcomes of events were unknown.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
12 hours post-administration; lethargic, malaise, lack of appetite, headache 16 hours post; chills, body aches, nausea 20 hours post;  wheezing
c/o Generalized itching ever since he had shingles shot 11/19/09. Itching neck, jaw, trunk, arms, legs. Saw Dermatologist - given CETAPHIL Lotion and triamcinalone cream 2x/day. Had to change soap and washing detergents, too. Says nothing helps. No rash. c/o itching. Follow-up information received 1-26-10.  Adverse event onset date is within a few days of first getting vaccine.
Hospital Course and Significant Findings:               The patient is 47 M with history of remote stroke admitted for COVID in vaccinated state. Treated with Dex for 4 days and RDV for 5 days. Discharged off oxygen.  Symptom onset 11/24, tested 11/28, isolation end based on 20 day protocol by CDC expected to end 12/14.21.  He was advised to boost with either Pfizer or Moderna after recovery.
This is a 77y.o. male with a past medical history significant for diabetes type 2, persistent atrial fibrillation, congestive heart failure with reduced EF,  Coronary artery disease, dyslipidemia, hypertension, history of myocardial infarction, post polio syndrome, prostate cancer status postradiation, sleep apnea on CPAP, valvular heart disease tricuspid regurgitation.  He presents to a local HCF on 1/12/2022 for evaluation of edema.  He is concerned that he is fluid overloaded with his history of congestive heart failure.  Patient states that he has been hospitalized recurrently for severe fluid overload, in the past requiring Lasix IV with Foley catheter placements.  Per reports in the emergency department he was requesting both of these.  Reports that since last discharge he has gained approximately 30 to 40 pounds.  He admits to leg and abdominal swelling with shortness of breath.  He is complaining of orthopnea. He states that he has had decreased urinary response to his lasix as of recently. States that he is retaining urine, has the urge to go but is unable to do so. He states that he was seen and evaluated by a urologist for the issue and instructed him to straight cath. He does state that he tested for COVID approximately 5 days ago, however is unsure of the results obtained. He does endorse a cough but thins it is because of fluid retention.  He is currently denying any chest pain.  Denies any fevers, chills, cough, nasal congestion, nausea, vomiting, diarrhea, abdominal pain.  He states that he did try getting in contact with his cardiologist today but however was not able to do so.
symptoms came back, also itchiness; Redness; Swelling; A spontaneous report was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling, erythema, pruritis.   The patient's medical history was not provided. No relevant concomitant medications were reported.     On 16-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown)  for prophylaxis of COVID-19 infection.   On 16-JAN-2021, The patient experienced swelling and   redness. Treated with antibiotics.  Action taken with mRNA-1273 in response to the events was not reported.   On 20-JAN-2021 swelling and redness were resolved on 20-JAN-2021 and came back with itching on 24-JAN-2021. At the time of this report, the outcome of the event not resolved.
vision and balance issues; vision and balance issues; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. On or about 05-DEC-2012, patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving zoster vaccine live (ZOSTAVAX), patient suffered vision and balance issues. As a result of these symptoms, patient was seen and treated by medical providers. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). Patient also experience mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), patient sustained severe and permanent personal injuries. Further, as a tragic consequence of company's wrongful conduct, patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of company's conduct, patient have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.Outcome of the events was not reported. The events were considered to be related to zoster vaccine live (ZOSTAVAX).
pt recvd vax & exp upper back discomfort & muscle aches; sx persist p/4 months;
First Covid-19 vaccination.  Moderna.  Injection into left anterior/lateral deltoid. At time of injection, felt warm stream down posterior aspect of left forearm to wrist. Within a couple of hours, slight ache in Left brachial region (lateral & anterior) turned into very deep achy pain.  I was and still am, unable to flex my left shoulder and raise my left arm anteriorly.  Constant achy pain in Left upper arm worsens at night, disrupting my sleep.  Pain is rated 10 on scale of 1 to 10.  Takes my breath away.  Only very slight improvement since onset.  When I try to flex my left shoulder, my left anterior brachial muscle quivers very painfully and no movement occurs.
Went to ER 2 days after receiving vaccine, with soreness, redness and swelling of (R) arm. Swelling from deltoid to elbow. Treated with antibiotics.
Red bumps which looked like blisters still on body to date 11/24/2021 - new ones every day on torso and thighs start out flesh color turn red then look like a scab.  They itch.
Mom called the clinic on 1/13/2015 and reported that child developed redness, swelling and was hot to touch. Was told to give Benadryl and use ice pack we offerd an appt. She did not show to appt. I called mom and she repoted that everything resolved after giving Benadryl.
Cold; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold). At the time of the report, NASOPHARYNGITIS (Cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment was reported.